Sundrug Co.,Ltd. (SDGCF)
USD 28.18
(0.0%)
USD 28.18
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 751.77 Billion JPY | 14365.3% |
| 2023 | 5.19 Billion JPY | -2.48% |
| 2022 | 5.32 Billion JPY | -7.16% |
| 2021 | 5.74 Billion JPY | 0.31% |
| 2020 | 5.72 Billion JPY | 7.71% |
| 2019 | 5.31 Billion JPY | 0.15% |
| 2018 | 5.3 Billion JPY | 11.88% |
| 2017 | 4.74 Billion JPY | 5.8% |
| 2016 | 4.48 Billion JPY | -98.99% |
| 2015 | 445.81 Billion JPY | -0.45% |
| 2014 | 447.81 Billion JPY | 9.92% |
| 2013 | 407.4 Billion JPY | 5.32% |
| 2012 | 386.83 Billion JPY | 7.26% |
| 2011 | 360.65 Billion JPY | 26.94% |
| 2010 | 284.11 Billion JPY | 22.18% |
| 2009 | 232.53 Billion JPY | 6.6% |
| 2008 | 218.13 Billion JPY | 10.3% |
| 2007 | 197.76 Billion JPY | 11.41% |
| 2006 | 177.5 Billion JPY | 15.3% |
| 2005 | 153.94 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.37 Billion JPY | 8.53% |
| 2024 Q1 | 1.26 Billion JPY | -1.91% |
| 2024 Q2 | 1.26 Billion JPY | 0.53% |
| 2024 Q4 | 185.8 Billion JPY | 13395.85% |
| 2024 FY | 751.77 Billion JPY | 14365.3% |
| 2023 FY | 5.19 Billion JPY | -2.48% |
| 2023 Q3 | 1.37 Billion JPY | 15.21% |
| 2023 Q2 | 1.19 Billion JPY | -2.65% |
| 2023 Q1 | 1.22 Billion JPY | -5.01% |
| 2023 Q4 | 1.28 Billion JPY | -6.43% |
| 2022 Q2 | 1.46 Billion JPY | -1.28% |
| 2022 Q1 | 1.47 Billion JPY | 6.47% |
| 2022 Q3 | 1.43 Billion JPY | -1.92% |
| 2022 Q4 | 1.29 Billion JPY | -9.91% |
| 2022 FY | 5.32 Billion JPY | -7.16% |
| 2021 Q2 | 159.61 Billion JPY | 1.77% |
| 2021 FY | 5.74 Billion JPY | 0.31% |
| 2021 Q1 | 156.84 Billion JPY | 2.25% |
| 2021 Q4 | 1.38 Billion JPY | -99.15% |
| 2021 Q3 | 164.31 Billion JPY | 2.94% |
| 2020 Q2 | 164.4 Billion JPY | 7.87% |
| 2020 FY | 5.72 Billion JPY | 7.71% |
| 2020 Q1 | 152.41 Billion JPY | 6.44% |
| 2020 Q3 | 147.55 Billion JPY | -10.25% |
| 2020 Q4 | 153.39 Billion JPY | 3.95% |
| 2019 FY | 5.31 Billion JPY | 0.15% |
| 2019 Q1 | 145.52 Billion JPY | 5.3% |
| 2019 Q2 | 147.18 Billion JPY | 1.14% |
| 2019 Q3 | 152.17 Billion JPY | 3.39% |
| 2019 Q4 | 143.18 Billion JPY | -5.91% |
| 2018 Q4 | 138.2 Billion JPY | -6.2% |
| 2018 Q3 | 147.33 Billion JPY | 4.74% |
| 2018 Q2 | 140.66 Billion JPY | 1.92% |
| 2018 Q1 | 138.01 Billion JPY | 6.97% |
| 2018 FY | 5.3 Billion JPY | 11.88% |
| 2017 FY | 4.74 Billion JPY | 5.8% |
| 2017 Q3 | 138.67 Billion JPY | 5.83% |
| 2017 Q2 | 131.03 Billion JPY | 1.05% |
| 2017 Q1 | 129.66 Billion JPY | 3.92% |
| 2017 Q4 | 129.01 Billion JPY | -6.96% |
| 2016 FY | 4.48 Billion JPY | -98.99% |
| 2016 Q2 | 125.53 Billion JPY | 3.19% |
| 2016 Q1 | 121.65 Billion JPY | 7.62% |
| 2016 Q3 | 131.8 Billion JPY | 5.0% |
| 2016 Q4 | 124.78 Billion JPY | -5.33% |
| 2015 FY | 445.81 Billion JPY | -0.45% |
| 2015 Q1 | 100.77 Billion JPY | -13.7% |
| 2015 Q4 | 113.04 Billion JPY | -6.35% |
| 2015 Q3 | 120.7 Billion JPY | 8.45% |
| 2015 Q2 | 111.3 Billion JPY | 10.45% |
| 2014 Q4 | 116.77 Billion JPY | 2.74% |
| 2014 FY | 447.81 Billion JPY | 9.92% |
| 2014 Q1 | 108.01 Billion JPY | 7.77% |
| 2014 Q2 | 109.37 Billion JPY | 1.26% |
| 2014 Q3 | 113.65 Billion JPY | 3.92% |
| 2013 Q4 | 100.22 Billion JPY | -6.67% |
| 2013 FY | 407.4 Billion JPY | 5.32% |
| 2013 Q1 | 97.79 Billion JPY | 3.39% |
| 2013 Q2 | 101.99 Billion JPY | 4.29% |
| 2013 Q3 | 107.39 Billion JPY | 5.3% |
| 2012 Q3 | 101.98 Billion JPY | 5.1% |
| 2012 Q2 | 97.02 Billion JPY | 4.06% |
| 2012 Q1 | 93.23 Billion JPY | 4.32% |
| 2012 FY | 386.83 Billion JPY | 7.26% |
| 2012 Q4 | 94.58 Billion JPY | -7.25% |
| 2011 Q1 | 86.26 Billion JPY | -7.59% |
| 2011 Q3 | 94.19 Billion JPY | 3.72% |
| 2011 Q2 | 90.81 Billion JPY | 5.28% |
| 2011 FY | 360.65 Billion JPY | 26.94% |
| 2011 Q4 | 89.37 Billion JPY | -5.11% |
| 2010 Q3 | 64.79 Billion JPY | 0.96% |
| 2010 Q1 | 61.78 Billion JPY | 0.0% |
| 2010 FY | 284.11 Billion JPY | 22.18% |
| 2010 Q4 | 93.35 Billion JPY | 44.08% |
| 2010 Q2 | 64.18 Billion JPY | 3.87% |
| 2009 FY | 232.53 Billion JPY | 6.6% |
| 2008 FY | 218.13 Billion JPY | 10.3% |
| 2007 FY | 197.76 Billion JPY | 11.41% |
| 2006 FY | 177.5 Billion JPY | 15.3% |
| 2005 FY | 153.94 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -384955.304% |
| Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -1687300988.542% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 20.28 Million USD | -3706277.491% |
| LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -572403.313% |
| MedGen, Inc. | 1.05 USD | -71597809523709.524% |
| Omni Health, Inc. | 4.69 Million USD | -16011193.866% |
| Oxford Investments Holdings Inc. | 61.16 Thousand USD | -1229056417.403% |
| Pineapple, Inc. | 381.89 Thousand USD | -196856848.336% |
| ScripsAmerica, Inc. | 30.85 Million USD | -2436410.717% |